Bladder Adenocarcinoma
5 clinical trials · Condition
◉ Watch Bladder Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer (NCT03912818) | Stanford University | 2019-04-10 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy (NCT00072137) | National Cancer Institute (NCI) | 2003-10-01 |
Track Bladder Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.